Coming October: SITC releases its late-breaking abstract titles. We’ll add their presenting authors’ institutions to this guide once they’re out.

Amgen at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Amgen brings 1 presentation to SITC 2026 in Phoenix. Its program centres on biotech financing and partnerships and on moving from academia into industry. On the science side, it shows that combining BiTE T-cell engagers with other treatment boosts tumor immunity in solid tumors through an interferon-gamma pathway.

OrganizationSITC 2026 Attendance
Amgen
Thousand Oaks, CA
amgen.com
Large pharma
Large biotechnology company whose oncology medicines include the bispecific T-cell engagers blinatumomab and tarlatamab.
Session
Thu Nov 5
12:00pm–1:30pm
Session
Thu Nov 5
7:00pm–7:50pm
Financing and Partnership Panel
Regulatory
Poster
Fri Nov 6
12:15–1:45pm
5:30–7pm

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Amgen

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction